Perceptions of teledermatology in the COVID-19 era: are patients ready for it?
10.4103/singaporemedj.SMJ-2021-290
- Author:
Dawn Ai Qun OH
1
;
Yi Wei YEO
1
;
Shiu Ming PANG
1
;
Choon Chiat OH
1
;
Haur Yueh LEE
1
;
Karen Jui Lin CHOO
1
Author Information
1. Department of Dermatology, Singapore General Hospital, Singapore.
- Publication Type:Journal Article
- Keywords:
COVID-19;
patient perception;
remote consultation;
teledermatology;
telemedicine
- MeSH:
Humans;
COVID-19/epidemiology*;
Dermatology/methods*;
Telemedicine;
Male;
Female;
Prospective Studies;
Middle Aged;
Adult;
Surveys and Questionnaires;
SARS-CoV-2;
Aged;
Perception;
Young Adult;
Pandemics;
Skin Diseases/diagnosis*;
Videoconferencing
- From:Singapore medical journal
2025;66(12):640-644
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:The COVID-19 pandemic has changed care provision models, with a rapid increase in the adoption of telemedicine to reduce in-person visits. Although there are many benefits to teledermatology, there are also factors that hinder its widespread adoption. We aimed to examine patients' perceptions of teledermatology to identify the barriers to its adoption.
METHODS:A prospective study was conducted from 15 June to 14 August 2020. Patients were invited to complete a questionnaire in an outpatient dermatology clinic via direct approach by clinical staff or posters posted at the door of consultation rooms.
RESULTS:Out of 2,276 clinic attendances, 997 survey responses (43.8%) were collected over a 3-month period. When asked if they would change their subsequent visit to teledermatology, 294 (29.5%) patients were keen, 166 (16.6%) were unsure and 537 (53.9%) declined. Significant factors for declining teledermatology were lack of prior exposure to videoconferencing ( P < 0.01) and lower educational level ( P = 0.019). Patients also raised concerns regarding the ability of teledermatology to address medical concerns (32.1%) and indicated a preference for face-to-face consultation (29.7%).
CONCLUSION:Factors that influence patients' decision to adopt teledermatology, such as concerns about its ability to address medical issues, lack of IT literacy or experience in teleconferencing, are modifiable. Targeted strategies such as careful patient selection, a dedicated teleconsultation workflow, and the use of a novel 'teledermatology patient journey' (including a clinic walkthrough at the first visit) and an intuitive audio-enabled user interface, may improve patient perceptions and adoption of teleconsultation service.
